These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12962009)

  • 1. Molecular targets in cancer therapy.
    Gale DM
    Semin Oncol Nurs; 2003 Aug; 19(3):193-205. PubMed ID: 12962009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the epidermal growth factor receptor as a target for cancer therapy.
    Wood LS
    Semin Oncol Nurs; 2002 Nov; 18(4 Suppl 4):3-10. PubMed ID: 12534148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenesis in cancer therapy.
    Muehlbauer PM
    Semin Oncol Nurs; 2003 Aug; 19(3):180-92. PubMed ID: 12962008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies: innovations in diagnosis and therapy.
    Baquiran DC; Dantis L; McKerrow J
    Semin Oncol Nurs; 1996 May; 12(2):130-41. PubMed ID: 8727800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy: current and future implications for oncology nursing practice.
    Lea DH
    Semin Oncol Nurs; 1997 May; 13(2):115-22. PubMed ID: 9114479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukins: the search for an anticancer therapy.
    Wheeler VS
    Semin Oncol Nurs; 1996 May; 12(2):106-14. PubMed ID: 8727798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
    Bellmunt J; Hussain M; Dinney CP
    Crit Rev Oncol Hematol; 2003 Jun; 46 Suppl():S85-104. PubMed ID: 12850530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Toxicity of Tyrosine Kinase Inhibitors.
    Davis ME
    Oncol Nurs Forum; 2016 Mar; 43(2):235-43. PubMed ID: 26906134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthroughs in cancer gene therapy.
    Liu K
    Semin Oncol Nurs; 2003 Aug; 19(3):217-26. PubMed ID: 12962011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological advances for new treatment approaches.
    Gemmill R; Idell CS
    Semin Oncol Nurs; 2003 Aug; 19(3):162-8. PubMed ID: 12962006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology and immunology.
    Mautner B; Huang D
    Semin Oncol Nurs; 2003 Aug; 19(3):154-61. PubMed ID: 12962005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of anti-EGFR therapy: a practical review.
    Khoukaz T
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):20-7. PubMed ID: 16616283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cancer therapy: role of monoclonal antibodies.
    Schmidt KV; Wood BA
    Semin Oncol Nurs; 2003 Aug; 19(3):169-79. PubMed ID: 12962007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of oral complications.
    Fulton JS; Middleton GJ; McPhail JT
    Semin Oncol Nurs; 2002 Feb; 18(1):28-35. PubMed ID: 11878036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of cancer.
    Robinson KD; Abernathy E; Conrad KJ
    Semin Oncol Nurs; 1996 May; 12(2):142-51. PubMed ID: 8727801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New opportunities for nurses as patient advocates.
    Morra ME
    Semin Oncol Nurs; 2000 Feb; 16(1):57-64. PubMed ID: 10701241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotherapy and the oncology nurse.
    Farrell MM
    Semin Oncol Nurs; 1996 May; 12(2):82-8. PubMed ID: 8727795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting symptom control in palliative care.
    Abrahm JL
    Semin Oncol Nurs; 1998 May; 14(2):95-109. PubMed ID: 9580933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinases as targets in cancer therapy - successes and failures.
    Traxler P
    Expert Opin Ther Targets; 2003 Apr; 7(2):215-34. PubMed ID: 12667099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.